Hepatocellular

Some articles on hepatocellular:

EGFL7 - Function - Cellular Migration
... Suppression of egfl7 expression inhibits the migration of hepatocellular carcinoma cells through an EGFR/FAK pathway ... In vivo, egfl7 knockdown expression in hepatocellular carcinoma cells decreases the number of intra-hepatic and pulmonary metastases ... In mice, inhibition of egfl7 in hepatocellular carcinoma cells decrease tumour growth and micro-vessel density ...
H19 (gene) - Role in Cancer - Hepatocellular Carcinoma
... In hepatocellular carcinoma, the expression of H19 and IGF2 usually changes from monoallelic to biallelic ... In in vitro studies, culturing hepatocellular carcinoma cell lines in hypoxic condition upregulated H19 expression ... the loss of imprinting for the H19 promoter is a characteristic of hepatocellular carcinoma is not known, as some cell lines exhibit loss of imprinting while others did not ...
Hepatocellular Carcinoma - Pathogenesis
... See also Carcinogenesis Hepatocellular carcinoma, like any other cancer, develops when there is a mutation to the cellular machinery that causes the cell to replicate at a higher rate and/or results in the cell ... chronic infections of hepatitis B and/or C can aid the development of hepatocellular carcinoma by repeatedly causing the body's own immune system to attack the liver cells, some of which are ... Aspergillus species of fungus is a carcinogen and aids carcinogenesis of hepatocellular cancer by building up in the liver ...
Fibrolamellar Hepatocellular Carcinoma
... Fibrolamellar hepatocellular carcinoma (FHCC) is a rare form of hepatocellular carcinoma that typically affects young adults and is characterized, under ...
Sorafenib - Clinical Studies - Liver
... results from the SHARP trial were presented, which showed efficacy of sorafenib in hepatocellular carcinoma ... Because of this trial Sorafenib obtained FDA approval for the treatment of advanced hepatocellular carcinoma in November 2007 ... not significantly delayed compared with doxorubicin alone in patients with advanced hepatocellular carcinoma ...